trending Market Intelligence /marketintelligence/en/news-insights/trending/zj9lmwrqvgow6qjdfctfdw2 content esgSubNav
In This List

Atara Biotherapeutics starts $150M common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Atara Biotherapeutics starts $150M common stock offering

Atara Biotherapeutics Inc. is selling $150 million of its common shares in an underwritten public offering.

The company also expects to grant the underwriters an option to buy up to an additional $22.5 million of common shares.

J.P. Morgan and Cowen are acting as joint book-running managers for the proposed offering.